EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exendin-4 improves mitochondrial integrity against cisplatin-induced cardiac damage: Targeting p53 and NF-κB pathways

Hnin Ei Ei Khine, Supachoke Mangmool, Warisara Parichatikanond

European Journal of Pharmacology · 2025

DOI: 10.1016/j.ejphar.2025.178233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmacology, 2025. Verfasst von Hnin Ei Ei Khine und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Pharmacy, Mahidol University, Bangkok, 10400, Thailand. Hauptthemen laut MEDLINE: Heart Failure, Cisplatin, Mitochondria, Heart, Exenatide. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Council of Thailand, Mahidol University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart failure is a devastating consequence of chemotherapy, with mitochondrial dysfunction playing a key role in cardiac damage. Cisplatin (CP), a widely used chemotherapeutic agent, induces cardiotoxicity by increasing apoptosis and triggering inflammation. This study provides evidence that exendin-4 (Ex-4), a glucagon-like peptide-1 (GLP-1) receptor agonist, exerts cardioprotective effects in H9c2 cardiomyoblasts against CP-induced injury. Ex-4 administration markedly restored mitochondrial bioenergetics, as evidenced by improved oxygen consumption and extracellular acidification rates, while preserving mitochondrial morphology and reversing fragmentation caused by CP. The observed effects were correlated with upregulation of markers involved in mitochondrial biogenesis (PGC1α, NRF1, ATP5A) and fusion process (OPA1, MFN1), accompanied by downregulation of mitochondrial fission markers (DNM1, FIS1). Ex-4 attenuated intracellular and mitochondrial reactive oxygen species (ROS) levels, repressed caspase-3/7 activity, and shifted apoptotic balance by enhancing Bcl-2 levels while diminishing BAX expression. Moreover, Ex-4 suppressed CP-triggered inflammatory responses by reducing TNFα and IL6 levels. Mechanistically, Ex-4 activated pro-survival signals (p-Akt and p-Erk1/2) and exerted cardioprotective effects through inhibition of p53 and NF-κB-dependent cascades. Pharmacological inhibition of p53 (pifithrin-α) or NF-κB (JSH-23) further amplified the protective effect of Ex-4 against CP-induced mitochondrial abnormalities, apoptosis, and inflammation, whereas activation of p53 (nutlin-3) or NF-κB (NF-κB activator 1) reversed these protective outcomes. Thus, Ex-4 emerges as a potent modulator of mitochondrial dysfunction and cellular stress through suppression of the p53 and NF-κB pathways, offering a promising therapeutic approach to mitigate CP-induced cardiotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureCisplatinMitochondria, HeartExenatideTumor Suppressor Protein p53NF-kappa BGlucagon-Like Peptide-1 Receptor AgonistsMyocardiumHeartCell LineAnimalsRatsMyoblasts, CardiacSignal TransductionBenzothiazolesToluenePhenylenediaminesAntineoplastic AgentsCardiotonic Agents

Stichwörter der Autor:innen

CardiotoxicityCisplatinExendin-4Mitochondrial dysfunctionNF-κBp53

Substanzen

CisplatinExenatideGlucagon-Like Peptide-1 Receptor AgonistsTp53 protein, ratTumor Suppressor Protein p53NF-kappa BpifithrinBenzothiazolesToluene4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine

Autor:innen und Institutionen

  • Department of Pharmacology, Faculty of Pharmacy, Mahidol University, Bangkok, 10400, Thailand.
  • Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, 50200, Thailand.
  • Department of Pharmacology, Faculty of Pharmacy, Mahidol University, Bangkok, 10400, Thailand; Center of Biopharmaceutical Science for Healthy Ageing, Faculty of Pharmacy, Mahidol University, Bangkok, 10400, Thailand; C…

Förderung

  • National Research Council of Thailand
  • Mahidol University

Zitieren

APA

Khine, H. E. E., Mangmool, S., & Parichatikanond, W. (2025). Exendin-4 improves mitochondrial integrity against cisplatin-induced cardiac damage: Targeting p53 and NF-κB pathways. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2025.178233

Vancouver

Khine HEE, Mangmool S, Parichatikanond W. Exendin-4 improves mitochondrial integrity against cisplatin-induced cardiac damage: Targeting p53 and NF-κB pathways. European Journal of Pharmacology. 2025. doi:10.1016/j.ejphar.2025.178233

BibTeX
@article{Khine2025,
  author = {Khine, Hnin Ei Ei and Mangmool, Supachoke and Parichatikanond, Warisara},
  title = {Exendin-4 improves mitochondrial integrity against cisplatin-induced cardiac damage: Targeting p53 and NF-κB pathways},
  journal = {European Journal of Pharmacology},
  year = {2025},
  doi = {10.1016/j.ejphar.2025.178233}
}
Kostenlos starten →